Boise State University

ScholarWorks
College of Health Sciences Poster Presentations

2010 Undergraduate Research and Scholarship
Conference

4-12-2010

Evaluation of the Respironics Bipap® Auto SV and
Resmed VPAP Adapt SV to Lung Simulator
Generated Central and Obstructive Sleep Apneic
Episodes.
Grant Drake
Department of Respiratory Care, Boise State University

Dawn Alverson
Department of Respiratory Care, Boise State University

This research was also published in the December 2009 issue of the Respiratory Care Journal.

AARC 2009

EVALUATION OF THE RESPIRONICS BIPAP® AUTO SV™ AND RESMED VPAP™ ADAPT SV
TO LUNG SIMULATOR GENERATED CENTRAL AND OBSTRUCTIVE SLEEP APNEIC
EPISODES.
EPISODES
Grant Drake,
Drake Dawn M.
M Alverson,
Alverson Jody Lester
Boise State University
University, Boise , ID,
ID
ABSTRACT
Background: Recent developments in non-invasive
non invasive positive pressure ventilation have led to the
production of adaptive servo
servo-ventilation
ventilation devices that examine an individual’s
individual s breathing characteristics
and adjust pressure levels via a product specific algorithm.
algorithm We evaluated two adaptive servoservo
ventilation devices
devices, the Respironics BiPAP® auto SV
SV™ and ResMed VPAP
VPAP™ Adapt SV to lung
simulator
i l t g
generated
t d central
t l and
d obstructive
b t ti sleep
l p apneic
p i episodes.
pi d
Methods: Each system was adjusted to the following settings: EPAP minimum 5 cmH2O, IPAP
maximum
i
15 cmH2O,
H2O adaptive
d ti modes,
d
15 b
breaths
th per minute.
i t Each
E h system
t
was tested
t t d using
i its
it own
brand of ventilation circuit and face mask (Respironics Comfort Gel ™Full
Full and Mirage Quattro)
Quattro). The
masks
k were fitted
fitt d to
t aL
Laerdal
d l Si
SimMan®
M ® version
i 2 mannequin
q i and
dd
demonstrated
t t d minimal
i i l lleak
k
levels The SimMan® was connected to a Hans Rudolph Electronic Breathing Simulator (HR 1101)
levels.
which generated 15 normal breaths followed by central and obstructive apneic episodes. The lung
simulator
i l t scripts
ipt were constructed
t t d with
ith the
th following
f ll i g parameters:
p
t
compliance
pli
40 cmH2O,
H2O amplitude
plit d
20 cmH2O
cmH2O, resistance ramped from 5 to 200 ml/sec during obstructive apnea simulation and
compliance
pli
40,
40, amplitude
pli d 0 and
d resistance
i
off 50
0d
during
i g centrall apnea
p
simulation.
i l i
Results: During simulated obstructive apnea the VPAP
VPAP™ Adapt SV delivered an average pressure of
7 53 cmH2O
7.53
H2O and
d an average
g Vt off 299
299.7
7 ml.
l M
Max/Min
/Mi p
pressures were 11.148
11 148 cmH2O
H2O and
d 5.104
5 104
cmH2O The BiPAP® auto SV™
cmH2O.
SV delivered an average pressure of 6.41
6 41 cmH2O with an average
delivered Vt of 257.2 ml. Max/min p
pressures were 11.8 cmH2O
O and 3.18 cmH2O.
O During
g simulated
central apnea the VPAP™ Adapt SV delivered an average pressure of 8.95
8 95 cmH2O and an average
Vt of 354
354.4
4 ml
ml. Max/min pressures were 14
14.5
5 cmH2O and 5
5.08
08 cmH2O . The BiPAP® auto SV™
SV
d li
delivered
d an average
g pressure
p
off 7.04
7 04 cmH2O
H2O and
d average
g Vt off 280
280.06
06 ml.l M
Max/Min
/Mi pressures
p
were
11 81 cmH2O and 3
11.81
3.22
22 cmH2O
cmH2O.
Conclusion: Each system responded adequately to both types of apnea however
however, some differences
were recognized.
recognized The VPAP
VPAP™ Adapt SV has more clinician definable parameters and our
observations
b
ti
were that
th t it performed
p f
d better
b tt in
i tests
t t simulating
i l ti g central
t l apneic
p i episodes.
pi d
We
W observed
b
d
that the BiPAP® auto SV
SV™ performed better during obstructive apneic episodes.
episodes Initially the BiPAP®
auto SV™
SV demonstrated a long rise time and delivered smaller volumes when respiratory rate was
set on “auto”;
auto ; using a set rate of 15 alleviated this discrepancy.
discrepancy
INTRODUCTION
INTRODUCTION:
Sleep disordered breathing (SDB) exists within varying patient populations and may occur secondary
to a number of pathologies
pathologies. The most common type of sleep disordered breathing is obstructive
sleep apnea
apnea. Individuals with obstructive sleep apnea experience nocturnal upper airway closure for
a minimum
i i
off tten seconds
d p
per apneic
p i episode.
pi d 1Individuals
I di id l will
ill experience
p i
loss
l
off flow
fl
and
d typically
typi lly
employ paradoxical type respiratory effort in an attempt to compensate.
compensate Obstructive type disordered
breathing carries a number of etiologies including maxillofacial malformation, increase in adipose
tissue distribution in neck and hypotonia of airway musculature.
musculature 2 Less common than obstructive
apnea is central sleep apnea.
apnea Central sleep apnea typically presents as an intermittent lack of
neurological
l gi l drive
d i to
t breath
b th .
The standard therapeutic modality for each type of apneic event is continuous positive airway
press re (CPAP) or bi-level
pressure
bi le el positive
positi e press
pressure
re (BiPAP)
(BiPAP)ventilation.
entilation The noct
nocturnal
rnal application of
positive pressure to the airways acts to splint open collapsed airways
airways. Positive pressure levels are
sett as a result
lt off p
polysomnographic
ly
g phi testing
t ti g and
d are patient
p ti t specific.
p ifi Application
Appli ti off traditional
t diti
l CPAP
and BiPAP therapy becomes problematic in patients who exhibit complex sleep apnea syndrome
(complex SAS), a condition which includes both obstructive and central type components, as well as
i patients
in
p ti t with
ith cheyne-stokes
h y
t k or other
th iirregular
g l breathing
b thi g patterns.
p tt
Adaptive
Ad pti servo-ventilation
til ti has
h
been developed to treat these patient types.
types

ResMed
R
M d and
d Respironics
R pi i h
have each
h developed
d
l p d units
it which
hi h feature
f t
adaptive
d pti servo-ventilation.
til ti
Each
E h
system utilizes a proprietary algorithm to provide this mode of ventilation
ventilation. ResMed’s
ResMed s website states:
“The
The VPAP™
VPAP Adapt SV is an adaptive servo
servo-ventilator
ventilator designed specifically to treat central sleep
apnea in all forms
forms, including complex and mixed sleep apnea
apnea. The adaptive servo algorithm: adapts
to the patient
patient’s
s ventilatory needs on a breath by breath basis
basis, automatically calculates a target
ventilation
til ti (90%
(
off the
th patient’s
p ti t’ recentt average
g ventilation)
til ti ) and
d adjusts
djj t the
th p
pressure support
pp t to
t
achieve it.
it ” (http://www
(http://www.resmed.com/us/products/vpap_sv/vpap-adapt-sv.html?nc=patients)
resmed com/us/products/vpap sv/vpap adapt sv html?nc=patients)
According to Respironics’
Respironics website, “The
The BiPAP® auto SV™
SV sleep therapy system is specifically
designed to be the best choice for managing complicated sleep-disordered
sleep disordered breathing patients.
patients It
combines a number of technologies to recognize and react to changing pressure needs”
needs and it “is
is
clinically
li i lly proven
p
to
t treat
t t obstructive,
b t ti , central
t l and
d complex
pl apneas
p
and
d hypopneas,
hyp p
, along
l g with
ith periodic
p i di
breathing ” (http://bipapautosv
breathing.
(http://bipapautosv.respironics.com/).
respironics com/)
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The ResMed VPAP™ Adapt SV and BiPAP® a
auto
to SV™ Respironics BiPAP® a
auto
to SV™ were
ere
examined for efficacy in response to both obstructive and central apnea.
apnea Each system was evaluated
on it’
it’s ability
bility tto p
provide
id clinically
li i lly therapeutic
th p ti pressure
p
levels,
l
l , llevels
l which
hi h may
yd
decrease airway
i
y
collapse in a majority of patients.
patients An average clinically effective pressure is 8 cmH2o for obstructive
sleep apnea. Response to Central apnea was considered to be effective if an exhaled tidal volume of
500 mll or more was measured
d via
i electronic
l t i b
breathing
thi g simulator.
i l t 3
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METHODOLOGY
METHODOLOGY:
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The Respironics unit was connected to a Respironics Comfort Gel ™ Full and the ResMed was
connected
t d to
t a Mirage
Mi g Quattro.
Q tt Both
B th masks
k were fitted
fitt d tto a L
Laerdal
d l SimMan
Si M ® version
i 2 mannequin.
q i
following standard mask fitting practice and demonstrated minimal leak
leak. The Laerdal SimMan ® was
then
h iinterfaced
f
d with
ihaH
Hans R
Rudolph
d lph El
Electronic
i Breathing
B
hi g Simulator
Si l
(HR1101)
(
) to simulate
i l
a sleep
l p
disordered breathing patient
patient.
We programmed the HR1101 to generate both obstructive and central apneic episodes
episodes. Scripts
were written
itt for
f th
the HR 1101 with
ith th
the following
f ll i g p
parameters:
t
Ob
Obstructive
t ti apnea
p
= Compliance
C pli
off 40
cmH2O,
O amplitude 20 cmH2O,
O resistance ramped from 5 to 20,
20 to 50
50, to 200 ml/sec and then an
apnea
ap
ea period.
pe od Ce
Central
a ap
apnea
ea = Compliance
Co p a ce of
o 40,
0, amplitude
a p ude 20,
0, 25,
5, 0, resistance
es s a ce 20,
0, 30, 50, and
a d
then an apnea period
period.
Each machine was set as follows: The ResMed VPAP
VPAP™ Adapt SV was at set: Mode ASV,
ASV EEP: 5
cmH
H2O,
O M
Mask:
k F
Fullll face,
f
Learn
L
Circuit,
Ci it Smart
S
t Stop:
St p off,
ff L
Leak
k alert:
l t off,
ff L
Low p
pressure support
pp t alarm:
l
on Minimum pressure support 3 (default value),
on,
value) Max Pressure support 15 (default value)
value). The
Respironics BIPAP® Auto SV™
SV was set at: Breath per minute 15, I time: 2 seconds, Rise time: 5,
Ramp setting: 0 minutes,
minutes IPAP max 15 cmH2O ,IPAP
IPAP Min 4 cmH2O,
O EPAP: 5 cmH2O,
O Apnea Setting
0 seconds
seconds.
Note: Initially the BiPAP® auto SV™ demonstrated a long rise time and delivered smaller volumes
when respiratory rate was set on “auto”;
auto ; using a set rate of 15 alleviated this discrepancy.
DATA COLLECTION:
The volumes and pressures that were generated by each machine were measured by the Hans
Rudolph Electronic Breathing Simulator (HR1101). The Hans Rudolph 1101 lung simulator was
calibrated per manufacturer’s standard calibration process prior to trials.
trials Data sample size was 50
milliseconds Data points were analyzed via a Microsoft Excel spreadsheet
milliseconds.
spreadsheet.
RESULTS:
Baseline values during the 14 test breaths leading up to the apnea episodes
Lung Simulator: Resistance 5,
5 Compliance 40
40, Amplitude 20:
R M d = Tidal
ResMed
Tid l Volume
V l
740 ml,l, IPAP 14.8
14 8 cmH2O,
H2O, EEP 5 cmH2O
H2O
Respironics = Tidal Volume 750 ml,
ml IPAP 10,
10 EPAP 5
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CONCLUSION
CONCLUSION:
Conclusion: Each system delivered tidal volume breaths of at least 190 ml or larger during
sim lated obstr
simulated
obstructive
cti e apnea and of 100 ml or larger during
d ring simulated
sim lated central apnea.
apnea In our
o r
abstract we reported averaged tidal volumes larger than actual delivered tidal volumes—
we h
had
d nott corrected
t d ffor th
the elevated
l
t db
baseline
li for
f volume.
l
If the
th comparison
p i
off
performance is based on actual delivered tidal volumes then both units are comparable.
comparable
When responding to simulated obstructive apnea. When responding to simulated central
apnea the
th R
Respironics
i i BIPAP® auto
t SV™ d
delivered
li
d an average
g off 21% more volume.
l
However if one uses a therapeutic target for tidal volume of 200 ml both units fell below
However,
thi target.
this
t g t
It is the opinion of the researchers that the ResMed VPAP
VPAP™ Adapt SV system
d
demonstrated
t t d a greater
g t ease off use to
t the
th clinician
li i i with
ith a more intuitive
i t iti user interface.
i t f
The VPAP™
VPAP Adapt SV also has more clinician definable parameters
parameters.
Initially when the BIPAP® auto SV™ was set to Auto it had excessively long rise times and
delivered smaller volumes; setting the system to a set rate of15 breaths per minute
minute,
alleviated
ll i t d this
thi p
problem.
bl
Thi
This may
y be
b off clinical
li i l importance.
i p t

